Safety of secukinumab treatment in COVID ‐19 affected psoriatic patients
Author:
Affiliation:
1. Dermatology Clinic, Department of Medical Sciences and Public Health University of Cagliari Cagliari Italy
Publisher
Wiley
Subject
Dermatology,General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.14710
Reference9 articles.
1. COVID-19 and immunomodulator/immunosuppressant use in dermatology
2. Should biologics for psoriasis be interrupted in the era of COVID-19?
3. Psoriasis health care in the time of the coronavirus pandemic: insights from dedicated centers in Sardinia (Italy)
4. Coronavirus disease 2019 (COVID-19) in a patient with ankylosing spondylitis treated with secukinumab: a case-based review
5. Status of a real-life cohort of patients with moderate-to-severe plaque psoriasis treated with secukinumab and considerations on the use of biological agents in the Covid-19 era
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Assessment of safety profile of secukinumab in real-world scenario using United States food and drug administration adverse event reporting system database;Scientific Reports;2024-01-12
2. Interplay between COVID-19 and Secukinumab treatment in Spondylarthritis patients during the omicron surge: a retrospective cohort study;Autoimmunity;2023-12-13
3. The mosaic of autoimmunity and autoinflammation and SARS-CoV-2 as an environmental factor;Autoimmunity, COVID-19, Post-COVID19 Syndrome and COVID-19 Vaccination;2023
4. Risk of COVID-19 infection, hospitalization and mortality in psoriasis patients treated with interleukin-17 inhibitors: A systematic review and meta-analysis;Frontiers in Immunology;2022-10-21
5. Blockade of interleukin seventeen (IL-17A) with secukinumab in hospitalized COVID-19 patients – the BISHOP study;Infectious Diseases;2022-04-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3